Stay updated on Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial
Sign up to get notified when there's something new on the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page.

Latest updates to the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter revision notes updated: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe Publications section now notes that publications are automatically filled from PubMed and the revision is updated to v3.3.2. The older PubMed-derived wording and the previous revision note (v3.2.0) were removed.SummaryDifference0.1%

- Check38 days agoChange DetectedThe government funding status banner on the page was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedNo significant additions or deletions were detected; the page content appears unchanged.SummaryDifference0.4%

- Check81 days agoChange DetectedAdds a government-operating status notice and upgrades the page version from v3.1.0 to v3.2.0, emphasizing updated operating status and links.SummaryDifference3%

- Check89 days agoChange DetectedUpgrade applied: from v3.0.2 to v3.1.0, indicating an update to the core content/version of the page.SummaryDifference0.1%

Stay in the know with updates to Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page.